A new study suggests insulin-like growth factor 1 can increase lithium sensitivity in bipolar patients for whom initial lithium treatment proved ineffective.
Based on prior findings, researchers propose that depressed levels of insulin-like growth factor (IGF) in the blood of newborns could potentially serve as a biomarker for the later development of autism.
